This is a multi-center, randomized, placebo-controlled, double-blind study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging in obese subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
120
Diagnamics, Inc.
Encinitas, California, United States
Ablon Skin Institute and Research Center
Manhattan Beach, California, United States
The Center for Clinical & Cosmetic Research
Aventura, Florida, United States
Skin Research Institute
Coral Gables, Florida, United States
Safety as measured by physical examination, adverse events, vital signs, and laboratory tests.
Physical examination, adverse events, vital signs, and laboratory tests.
Time frame: 9 weeks
Change in waist circumference.
Time frame: 9 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tennessee Clinical Research Center
Nashville, Tennessee, United States
Charlottesville Medical Research Center
Charlottesville, Virginia, United States